084203093	084203093	CD	B-NP	O
|	|	NN	I-NP	O
TCH	TCH	NN	I-NP	O
|	|	NN	I-NP	O
83539961	83539961	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9596721	9596721	CD	B-NP	O
|	|	CC	I-NP	O
7/16/2006	7/16/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RIGHT	RIGHT	NNP	I-NP	I-protein
UPPER	UPPER	NNP	I-NP	I-protein
LOBE	LOBE	NNP	I-NP	I-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/2006	5/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2006	6/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DAIS	DAIS	NNP	B-NP	O
,	,	,	O	O
PASQUALE	PASQUALE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Community	Community	NNP	B-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Cough	Cough	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60-year-old	60-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
prior	prior	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
25	25	CD	I-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
5/10	5/10	CD	B-NP	O
in	in	IN	B-PP	O
severity	severity	NN	B-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
this	this	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
right-sided	right-sided	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
pleuritic	pleuritic	JJ	I-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
or	or	CC	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denies	deny	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
or	or	CC	I-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
slow	slow	JJ	B-NP	O
speech	speech	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
weakness	weakness	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
EMS	EMS	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
secretions	secretion	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
,	,	,	I-NP	O
cefpodoxime	cefpodoxime	NN	I-NP	O
,	,	,	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
,	,	,	I-NP	O
captopril	captopril	NN	I-NP	O
and	and	CC	I-NP	O
Trileptal	Trileptal	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
three-vessel	three-vessel	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
stroke	stroke	NN	B-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
subclavian	subclavian	JJ	I-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
SVC	SVC	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
Zocor	Zocor	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Trileptal	Trileptal	JJ	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
450	450	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Sensipar	Sensipar	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prozac	Prozac	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
but	but	CC	O	O
none	none	NN	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
or	or	CC	I-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
rehab	rehab	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
who	who	WP	B-NP	O
live	live	VBP	B-VP	O
in	in	IN	B-PP	O
Gard	Gard	NNP	B-NP	O
Seyriuxralden	Seyriuxralden	NNP	I-NP	O
Terb	Terb	NNP	I-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
53	53	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
143/52	143/52	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
with	with	IN	B-PP	O
slow	slow	JJ	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
right-sided	right-sided	JJ	I-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
muscles	muscle	NNS	I-NP	O
intact	intact	JJ	B-NP	O
,	,	,	I-NP	O
moist	moist	JJ	I-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
3/6	3/6	CD	B-NP	O
harsh	harsh	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
heard	hear	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
carotids	carotid	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Decreased	Decrease	VBD	B-VP	O
respiratory	respiratory	JJ	B-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
egophony	egophony	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rhonchi	rhonchi	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
normoactive	normoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
sacrum	sacrum	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II-XII	II-XII	NN	B-NP	B-protein
intact	intact	JJ	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
weakness	weakness	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
3.3	3.3	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
od	od	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
BNP	BNP	NN	B-NP	O
7900	7900	CD	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
3.1	3.1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36	36	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
248	248	CD	B-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
new	new	JJ	I-NP	O
ST	ST	JJ	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
;	;	:	O	O
PA	PA	NN	B-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-VP	O
showed	show	VBD	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
ill-defined	ill-defined	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
likely	likely	JJ	I-NP	O
representing	represent	VBG	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	B-protein
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cavitary	cavitary	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
nodule	nodule	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
8	8	CD	B-NP	O
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	O	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
approximately	approximately	RB	B-NP	O
every	every	DT	I-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
with	with	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
calcifications	calcification	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
somewhat	somewhat	RB	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
secretions	secretion	NNS	B-NP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
nasal	nasal	JJ	B-NP	O
swabs	swab	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
influenza	influenza	NN	B-NP	O
A	A	NN	I-NP	O
&	&	CC	I-NP	O
P	P	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PPD	PPD	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2006	2006	CD	B-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
sputum	sputum	NN	I-NP	O
cultures	culture	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
AFB	AFB	NN	B-NP	O
smears	smear	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
acid	acid	NN	B-NP	O
fast	fast	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
completed	complete	VBN	I-VP	O
a	a	DT	B-NP	O
5-day	5-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
to	to	TO	I-VP	O
complete	complete	VB	I-VP	O
another	another	DT	B-NP	O
5	5	CD	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
have	have	VBP	B-VP	O
outpatient	outpatient	NN	B-NP	O
that	that	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
admitted	admit	VBN	I-VP	O
administered	administer	VBN	B-VP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
cavitary	cavitary	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
however	however	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
that	that	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
with	with	IN	B-PP	O
interval	interval	JJ	B-NP	O
CAT	CAT	NN	I-NP	O
scans	scan	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
glucan	glucan	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
tests	test	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
currently	currently	RB	I-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
negative	negative	JJ	B-NP	O
culture	culture	NN	I-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
tuberculosis	tuberculosis	NN	B-NP	O
precautions	precaution	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
cavitary	cavitary	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
PPD	PPD	NN	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
TB	TB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
extremely	extremely	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
precautions	precaution	NNS	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
honey	honey	NN	I-NP	O
thick	thick	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
diet	diet	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
possibly	possibly	RB	I-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	NN	I-NP	O
examination	examination	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bed	bed	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
hypercalcemia	hypercalcemia	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
electrophoresis	electrophoresis	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
calcium	calcium	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
during	during	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
PTH	PTH	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
pending	pende	VBG	I-VP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
undergoes	undergo	VBZ	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
this	this	DT	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Alllou	Alllou	NNP	I-NP	O
Lorda	Lorda	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
at	at	IN	B-PP	O
Son	Son	NNP	B-NP	O
Prai	Prai	NNP	I-NP	O
,	,	,	O	O
9275118904	9275118904	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
on	on	IN	B-PP	O
Nephrocaps	Nephrocap	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
recent	recent	JJ	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
Beta-blocker	Beta-blocker	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
examination	examination	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
PPI	PPI	NN	B-NP	B-protein
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
care	care	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
consult	consult	NN	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
stage	stage	NN	I-NP	O
2	2	CD	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
DuoDERM	DuoDERM	NNP	B-NP	O
dressing	dress	VBG	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
benefits	benefit	VBZ	B-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
air	air	NN	I-NP	O
mattress	mattress	NN	I-NP	O
and	and	CC	I-NP	O
vitamin	vitamin	NN	I-NP	O
C	C	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
TSH	TSH	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.12	1.12	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Prozac	Prozac	NN	B-NP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
Trileptal	Trileptal	NNP	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
seizure	seizure	NN	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full-code	full-code	JJ	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
not	not	RB	O	O
to	to	TO	B-VP	O
exceed	exceed	VB	I-VP	O
4	4	CD	B-NP	O
grams	gram	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	B-protein
nebulizer	nebulizer	NN	I-NP	I-protein
2.5	2.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
nebs	neb	NNS	I-NP	I-protein
every	every	DT	B-NP	I-protein
4	4	CD	I-NP	I-protein
hours	hour	NNS	I-NP	I-protein
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
cefpodoxime	cefpodoxime	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
more	more	JJR	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Trileptal	Trileptal	JJ	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
450	450	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
every	every	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
loose	loose	JJ	B-NP	O
stool	stool	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Zinc	Zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
fourteen	fourteen	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

TO	TO	TO	B-PP	O
DO	DO	NNP	B-NP	O
LIST	LIST	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
for	for	IN	B-PP	O
sacral	sacral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
serum	serum	NN	B-NP	O
protein	protein	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	B-protein
CT.	CT.	NNP	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
have	have	VBP	B-VP	O
repeat	repeat	NN	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	B-VP	O
current	current	JJ	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
every	every	DT	O	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-2389403	7-2389403	CD	B-NP	O
RSSten	RSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Wiley	Wiley	NNP	B-NP	O
Ricky	Ricky	NNP	I-NP	O
Mumm	Mumm	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
DRPH	DRPH	NNP	B-NP	O
Mond	Mond	NNP	I-NP	O
Revetroit	Revetroit	NNP	I-NP	O
Pitgas	Pitgas	NNP	I-NP	O
Ven	Ven	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WAUCH	WAUCH	NNP	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
POWLESS	POWLESS	NNP	B-NP	O
,	,	,	O	O
STUART	STUART	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3878727	3878727	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
4/10/06	4/10/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/10/06	4/10/06	CD	B-NP	O

